English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Regulatory
+
Regulatory
H. K. Adler
| Jul 7, 2026
Save Our States: '340B drug discount program is being abused while nonprofit hospitals spend big on luxury renovations'
+
Regulatory
Patient Daily
| Jul 7, 2026
Neurology nurse practitioner Celia McIntosh discusses career path and specialty challenges
+
Regulatory
A. B. Adkins
| Jul 6, 2026
COA executive director: '340B dollars are meant for patients in need, not corporate profits'
+
Regulatory
A. K. Velazquez
| Jul 1, 2026
Partnership for Innovation and Empowerment: Nonprofit hospitals 'rake in profits and charge patients more'
+
Regulatory
Patient Daily
| Jun 30, 2026
AANP welcomes interim guidance on federal student loan access for graduate nursing programs
+
Regulatory
Patient Daily
| Jun 29, 2026
Public Policy Solutions: Hospitals are 'panicking over basic accountability'
+
Regulatory
A. P. Berry
| Jun 25, 2026
Pharmacy benefits consultant: 'Most plan sponsors have never been shown' the generic spread their PBM charges
+
Regulatory
Patient Daily
| Jun 25, 2026
Real America's Voice: 340B program envisioned for neighborhood clinics has grown into 'taxpayer-supported enterprises'
Trending
+
Pharmaceuticals
Patient Daily
| Aug 4, 2026
Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+
Pharmaceuticals
Patient Daily
| Aug 6, 2026
FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+
Regulatory
M. R. Armstrong
| Aug 4, 2026
Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+
Pharmaceuticals
Patient Daily
| Aug 5, 2026
Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes
« First
«
1
2
3
4
5
…
»
Last »